The current COVID-19 pandemic, this is especially since the transmission of SARS-CoV-2 is thought to occur mainly through respiratory droplets generated by coughing and sneezing, by direct contact with contaminated surfaces and because in a large number of patients COVID-19 disease may be asymptomatic. As recommended by the CDC medical personnel should be equipped with full personal protective equipment (PPE) for AGP in contact with suspected/confirmed COVID-19 patient. Therefore, it is reasonable to search for the most effective methods of intravascular access in those conditions.
Study Type
INTERVENTIONAL
Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
SINGLE
Enrollment
60
obtaining intravascular access using a ready intravenous NIO needle set
obtaining intravascular access using a standard intravenous cannula
Lazarsku University
Warsaw, Masovian Voivodeship, Poland
Success rate of first intravascular access attempt
successful placement of intravascular device
Time frame: 1 day
time to successful access
time to successful access
Time frame: 1 day
number of attempts to successful access
number of attempts to successful access
Time frame: 1 day
time to infusion
time to therapy including but not limited to time to fluids, antibiotics, and antiarrythmics
Time frame: 1 day
complication rates
complication rates
Time frame: 1 day
ROSC
the rate of survival to hospital admission
Time frame: 1 day
This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.